/Investor DB

Pangaea Ventures Us Inc. — 2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

Calystacalysta.comin𝕏Jun 2019

Calysta produces protein ingredients through a patented fermentation platform that does not use arable land, plants, or animal products, offering products such as FeedKind and Positive Protein for animal feed and food.

AgTechBiotechFoodTechMenlo Park, US

Alan Shaw, Ph.D.(President, CEO and Co-Founder)Alan Shaw(President, Chief Executive Officer and Co-Founder)inAlan Shaw, PhD(Founder)inLori Giver(Chief Science and Sustainability Officer)inCraig Barratt, Ph.D.(Director)David Hayes(Director)

Co-investorsAqua SparkBaruch Future VenturesCelesta CapitalSQN Venture Partners, LLCWestern Technology Investmentbp ventures+1 more

Modulimmodulim.comin𝕏Series B · Jan 2019 · $7M

Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications.

Digital HealthHealthtechMedical DevicesIrvine, US

David J. Cuccia(Founder & Chief Technology Officer)inCharlie Huiner(President & Chief Executive Officer)inAmaan Mazhar(Chief Product Officer)in

Co-investorsFresenius Medical Care Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.